Market News / Story
Hemostemix Inc. (HEM) Gets Full LARTA Approval, Starts C$1.0M Placement
·
Hemostemix received full LARTA ethics approval in The Bahamas for a commercial Phase 1 VesCell study and filed for price protection on a non-brokered placement of up to C$1.0M, with an initial close of C$380.5K via 7.61M units at C$0.05. Material Details #DetailAI Analyst View1Full LARTA ethics approvalEnables commercial Phase 1 VesCell study in The Bahamas, a step toward potential revenue in that market.2Placement up to C$1.0M filedFinancing runway extension; signals…